Last reviewed · How we verify

NCT03302624: SURIA

Follow-up of Long-term Renal Function After Acute Kidney Injury in ICU

Status unknown Last updated 6 October 2017
What this trial tests

trial in Acute Kidney Injuries in 506 participants. Status unknown.

Timeline
1 September 2017
Primary endpoint
1 December 2017
31 December 2017

Quick facts

Lead sponsorUniversity Hospital, Clermont-Ferrand
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment506
Start date1 September 2017
Primary completion1 December 2017
Estimated completion31 December 2017
Sites1 location across France

Conditions studied

Sponsor

University Hospital, Clermont-Ferrand

Who can join

18 and older, any sex, with Acute Kidney Injuries or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute kidney injury (AKI) involves poor prognosis in ICU patients. The renal prognosis at long term is unknown. The study will determine chronic kidney injury incidence and quality of life, five years after AK during ICU stay.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.
    Soum E, Timsit JF, Ruckly S, Gruson D, et al · · 2022 · cited 7× · PMID 36447221 · DOI 10.1186/s13054-022-04233-4

Verify or expand the search:

Other recruiting trials for Acute Kidney Injuries

Currently open trials in the same condition.

Other University Hospital, Clermont-Ferrand trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03302624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing